[ad_1]
fake images
SAO PAULO – Pfizer (PFIZ34) announced, on Thursday (3), that it should ship half of the doses of its Covid-19 vaccine originally planned for 2020, after discovering that the raw materials used in the start of production do not meet their standards, according to sources cited by the Wall Street Journal (WSJ).
The company expected to ship 100 million doses to various countries by the end of this year, but with the unexpected, the volume should drop to 50 million.
Even so, Pfizer still plans to deliver more than 1 billion doses of the immunizer produced in partnership with the German BioNTech in 2021.
“Expanding the supply chain of raw materials for the vaccine took longer than expected,” said a company spokeswoman. WSJ. “And it’s important to note that the result of the clinical trial was released shortly after the initial screening.”
Shares of the US pharmaceutical company, which is listed on the US stock exchange Nasdaq, closed Thursday down 1.74%. At after market, newspapers posted a 0.65% drop around 6:30 pm.
The station CNBC It also confirms the reduction in the delivery of doses in 2020, but says that Pfizer shares were not affected as much by the news because the report published by the pharmaceutical companies Pfizer and BioNtech says the plan to launch 1.3 billion vaccines in 2021 has not changed. and the deficit of 50 million doses this year should be covered with an increase in production next year.
Race for vaccines
This week, the UK approved the emergency use of the vaccine from Pfizer and BioNTech and became the first Western country to launch a vaccine, ahead of decisions by the United States and the European Union. With the emergency authorization, the expectation is that the vaccine will begin to be distributed to the British from next week.
To date, only four vaccines in the world, of the ten that are in phase three testing, the last before approval, have shown efficacy results: the Pfizer vaccine in association with BioNTech (95% effective); that of Moderna (94% effective); that of Oxford in partnership with Astra Zeneca (up to 90% effective, but with later questioned results) and the Sputinik V vaccine, from the Russian laboratory Gamaleya (92% effective).
On Thursday, the governor of São Paulo, João Doria, and the director of the Butantan Institute, Dimas Covas, said that the CoronaVac vaccine, produced by the Chinese pharmaceutical Sinovac, in partnership with Butantan and the São Paulo government, must present its results. . effective December 15.
Is it possible to trade with only R $ 25? The analyst shows how to take the first trade, meet daily profit targets, and control risks. Sign up free!
[ad_2]
